Integrated stress response (ISR) is a signaling system in which phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) by stress-specific kinases and subsequent activation of activation transcription factor (ATF) 4 help restore cellular homeostasis following exposure to environmental stresses. ISR activation has been observed in metabolic diseases, including hepatic steatosis (HS), steatohepatitis (SH), and insulin resistance (IR), but it remains unclear whether ISR contributes to disease pathogenesis or represents an innate defense mechanism against metabolic stresses. Constitutive repressor of eIF2α phosphorylation (CReP) is a critical regulatory subunit of the eIF2α phosphatase complex. Here, we show that CReP ablation causes constitutive eIF2α phosphorylation in the liver, which leads to activation of the ATF4 transcriptional program including increased fibroblast growth factor 21 (FGF21) production. Liver-specific CReP knockout (CReP 
specifically activated by distinct stress signals and commonly phosphorylate eIF2α at the Ser-51 residue.
(1) eIF2α phosphorylation decreases the efficiency of translational initiation, but paradoxically increases the translation of certain mRNAs that possess short open reading frames in the 5′ untranslated regions (UTRs). It is well known that mRNAs encoding activation transcription factor (ATF) 4 and ATF5 are more efficiently translated as eIF2α phosphorylation is increased. ATF4 is considered a master transcriptional regulator of ISR and induces a variety of genes, such as those involved in amino acid biosynthesis and redox regulation. (2) eIF2α phosphorylation is also regulated by phosphatase complexes, which are composed of the catalytic subunit of protein phosphatase 1 (PP1) and regulatory subunits, growth arrest and DNA damage-inducible protein 34 (GADD34; encoded by PPP1R15A), or constitutive repressor of eIF2α phosphorylation (CReP; encoded by PPP1R15B). (3) GADD34 is induced by endoplasmic reticulum (ER) stress in a PERK-dependent manner, constituting a negative feedback loop regulating eIF2α phosphorylation. (4) CReP was initially identified as a constitutively expressed PP1 activator that determines the basal level of eIF2α phosphorylation. (3) However, recent study demonstrates that CReP abundance is dynamically regulated at the transcriptional, posttranscriptional, and posttranslational levels, and the abundance of CReP protein is a critical determinant of eIF2α phosphorylation. (5) (6) (7) Independent of PP1 regulation, CReP can localize to membrane of intracellular vesicles and regulate membrane traffic. (8) Increased eIF2α phosphorylation has been observed in livers with steatosis and nonalcoholic and alcoholic hepatitis, (9) (10) (11) (12) (13) (14) but the physiological functions of ISR activation in these diseases remain unclear. Several studies suggested that ISR activation contribute to pathogenesis of liver steatosis (LS). ATF4 has been shown to activate lipogenesis in hepatocytes (15) (16) (17) and increase the expression of hepatic very-low-density lipoprotein receptor, which contribute to worsened hepatic steatosis (HS). (18) In line with this, ISR inhibition by transgenic overexpression of GADD34 in the liver suppressed lipogenesis and protected mice from HS. (19) On the other hand, ISR has recently been identified as a potent inducer of a pleiotropic metabolic hormone, fibroblast growth factor 21 (FGF21), in response to various stresses. (20) (21) (22) (23) Notably, it has been shown that GCN2-or HRI-mediated FGF21 induction improves HS and glucose intolerance in mice. (24, 25) In the present study, we aimed to determine whether ISR activation represents a part of a pathogenic mechanism in diseased organs or an innate defense mechanism against metabolic stresses. We generated mutant mice lacking CReP selectively in hepatocytes and demonstrated that CReP ablation activated ISR independent of stresses. Surprisingly, we found that the constitutive ISR activation caused a profound browning of white adipose tissues (WATs) and increased whole-body energy expenditure and insulin sensitivity, which led to protection from highfat diet (HFD)-induced adiposity, insulin resistance (IR), and HS in mice. We further demonstrated that the endocrine fibroblast growth factor, FGF21, plays a critical role in the metabolic benefits conferred by ISR activation. Our data suggest that augmenting ISR could be a therapeutic approach to treat metabolic diseases.
Materials and Methods

geNeRatIoN oF MICe laCKINg CRep IN tHe lIVeR (CRep lKo )
A 7.7-kilobase mouse genomic DNA fragment containing Pppa1r15b gene was retrieved from a BAC clone (RP23-304O9; Roswell Park Cancer Institute, Buffalo, NY) by recombineering. (26) A targeting vector containing two loxP sites, one in the first intron and the other one 222 base pairs downstream of CReP coding region, and a FRT-NEO-FRT cassette were generated as described elsewhere. (27) Mouse embryonic stem (ES) cells were transfected with the targeting vector to obtain a recombined clone. Targeted ES cells were injected into C57BL/6 blastocysts to produce Ppp1r15b loxP ;FRT-NEO-FRT mice. FRT-NEO-FRT cassette was removed by mating to Flp recombinase transgenic mice. Ppp1r15b loxP mice were backcrossed for more than five generations onto a C57BL/6 background and crossed to Albumin-cre (B6.Cg-Tg(Alb-cre)21Mgn/J; Jackson Laboratory, Bar Harbor, ME) mice to generate liver-specific CReP knockout (CReP LKO) mice. To generate liver-specific CReP and Fgf21 double-knockout (DKO) mice, CReP LKO mice were crossed with Fgf21 loxp (B6.129S6(SJL)-Fgf21tm1.2Djm/J; Jackson Laboratory) mice.
DIetS aND aNIMal eXpeRIMeNtS
Mice were fed either standard chow diet containing 13.2% fat, 24.6% protein, and 62.1% carbohydrate (kcal/100 kcal; #5053; LabDiet, St. Louis, MO) or an HFD containing 60% fat, 20% protein, and 20% carbohydrate (#D12492; Research Diets, New Brunswick, NJ). Mice were housed in a 12-hour light/dark cycle with ad libitum access to food and water. For the glucose tolerance test (GTT), mice were fasted overnight for 16 hours with free access to water and injected intraperitoneally with 4.5 g/kg of glucose. For ITT, mice were fasted 4 hours before being intraperitoneally injected with human insulin (0.75 U/kg; Eli Lilly, Indianapolis, IN). For tunicamycin injection, a dose of 2 mg/kg of tunicamycin in 150 mM of dextrose were intraperitoneally injected and mice were sacrificed after 6 hours for further analysis. Male mice around 2 months old with body weight (BW ) of 24 ± 1 g were used unless otherwise indicated. All animal experiments were approved by the Weill Cornell Medical College Institutional Animal Care and Use Committee.
SeRuM aND lIVeR MetaBolIteS MeaSuReMeNt
Mice were euthanized by CO 2 following the recommended procedure of the American Veterinary Medical Association (AVMA Euthanasia Panel Report). Plasma was obtained from blood samples collected with Microvette CB 300LH (SARSTEDT, Nümbrecht, Germany). Tissues were resected, snap-frozen, and stored at −80°C until further analysis. Plasma triglyceride (TG), nonesterified fatty acid (NEFA), ketone bodies, alanine aminotransferase (ALT), insulin, FGF21, albumin, and haptoglobin concentrations were determined using commercial assay kits ( Lipids were extracted from liver tissues with chloroform/methanol mixture (2:1 v/v) and quantitated using the Serum Triglyceride Determination Kit (Sigma-Aldrich), as described. (28) All assays were performed according to the manufacturer's instructions. Blood glucose levels were measured using the Ascensia Breeze 2 Blood Glucose Monitoring System (Bayer, Leverkusen, Germany).
WeSteRN BlottINg aNalySIS
Whole-tissue lysate for adipose tissues and liver was prepared by homogenization in radioimmunoprecipitation assay buffer. Liver nuclear extracts were prepared, as described. (29) For western blotting analysis, the following primary antibodies were used: CReP (Proteintech, Rosemont, IL, 14634), phospho-eIF2α (Cell Signaling, Danvers, MA, 9721), eIF2α (Santa Cruz, Dallas, TX, sc-133132), PERK (Cell Signaling, 3192), GCN2 (Cell Signaling, 3302), ATF4/ cAMP-response element binding protein 2 (Santa Cruz, sc-200), ATF5 (Proteintech, 15260), Lamin B1 (Santa Cruz, sc-56145), uncoupling protein 1 (UCP1; Abcam, ab10983), PPARα (Santa Cruz, sc-9000), Perilipin (Cell Signaling, 9349), phospho-AKT (protein kinase B; Cell Signaling, 9208), and AKT (Cell Signaling, 9272). Antibodies for cAMP-response element-binding protein H (CREBH), apolipoprotein (Apo)B, ApoE, inositol requiring enzyme 1α (IRE1α), spliced X-box-binding protein 1 (XBP1s), and ATF6α were described. (29, 30) Phos-tag western blotting was performed as described. (29) 
StatIStICal aNalySIS
All data are expressed as mean ± SEM for experiments including numbers of mice or duplicates as indicated. The two-tailed Student t test was used to evaluate statistical differences between groups. Two-way analysis of variance (ANOVA) with replication was performed to analyze data obtained with time-course experiments. Statistics of significance is expressed as the number of asterisks: *P < 0.05; **P < 0.01; ***P < 0.001.
Results
CRep aBlatIoN INCReaSeS eIF2α pHoSpHoRylatIoN aND aCtIVateS atF4-DepeNDeNt tRaNSCRIptIoN pRogRaM IN tHe lIVeR
To determine the role of CReP in eIF2α phosphorylation in the liver, we generated liver-specific CReP knockout (CReP and Cre recombinase-mediated deletion of exon 2 is expected to produce C-terminal truncated CReP protein devoid of PP1 and eIF2α binding domains (Supporting Fig. S1A ). (31) Contrary to the full-length CReP, overexpression in HeLa cells of the mutant CReP lacking exon 2 sequences failed to suppress UV-mediated eIF2α phosphorylation, confirming that the mutant protein is incapable of promoting eIF2α dephosphorylation (Supporting Fig. S1B ). Both wild type (WT) and mutant CReP were rapidly degraded by UV irradiation (Supporting Fig. S1B ), consistent with a previous report.
(5) Efficient CReP ablation in CReP LKO liver was confirmed by western blotting and quantitative RT-PCR analyses ( Fig. 1A and Supporting Fig. S1C ). CReP LKO mice were born at a normal Mendelian ratio and appeared grossly normal. Interestingly, liver to body weight ratio was reduced by 14% in CReP LKO mice (Supporting Fig. S1D ). Liver damage was not observed in CReP LKO mice, as determined by histological analysis of liver sections and ALT assay (Fig. 1B,C) . Plasma protein concentrations and levels of major liver-secreted proteins, such as albumin, haptoglobin, and ApoB and ApoE, were comparable between WT and CReP LKO mice ( Fig. 1D and Supporting Fig. S2A -E). These data suggested that CReP deletion had minimal effect on protein synthetic and secretory function of the liver.
eIF2α phosphorylation was markedly increased in CReP LKO livers ( Fig. 1A and Supporting Fig. S1E ), suggesting that CReP expression is critical for eIF2α dephosphorylation in hepatocytes. Consistent with induction of eIF2α phosphorylation, ATF4 and ATF5 proteins were markedly induced in CReP LKO livers (Fig. 1A) . mRNA levels of ATF4-dependent genes, such as Atf5, asparagine synthetase (glutaminehydrolyzing) (Asns), and phosphoserine aminotransferase 1 (Psat1), were also increased in CReP LKO livers (Fig. 1E ). FGF21, a liver-derived hormone exerting various metabolic benefits, was highly expressed in CReP LKO livers, consistent with previous studies demonstrating the role of ATF4 in FGF21 expression. (20) (21) (22) Notably, certain ATF4-dependent ER stress-inducible genes, such as heat shock 70 kDa protein 5 (Hspa5), DNA damage-inducible transcript 3 (Ddit3), and protein phosphatase 1 regulatory subunit 15A (Ppp1r15a), were not induced or only minimally induced in CReP LKO livers (Fig. 1E ), indicating that the ISR activation by CReP deletion is qualitatively different from stress-mediated UPR. On the other hand, other ER stress markers, such as phospho-PERK, phospho-IRE1α, XBP1s, and the nuclear ATF6α proteins, were not increased in CReP modestly reduced in CReP LKO livers, likely reflecting reduced basal stress level (Fig. 1A) . Representative unfolded protein response markers were comparably expressed between WT and CReP LKO mice in both basal and HFD-fed conditions (Supporting Fig.  S3C,D) . Tunicamycin, an ER stress-inducing agent, strongly activated ER stress markers (Fig. 1A) and induced ER stress-responsive genes in both WT and CReP LKO livers (Fig. 1E) . Interestingly, CReP LKO mice exhibited modestly reduced expression of a subset of ER stress response genes, such as DnaJ heat shock protein family (Hsp40) member B9, DnaJ heat shock protein family (Hsp40) member C30, ER degradation enhancing alpha-mannosidase like protein 1, ERO1-like (S. cerevisiae), heat shock protein 90 beta family member 1, and protein disulfide isomerase family A member 3, compared to WT mice upon tunicamycin treatment (Supporting Fig. S3A ), suggesting that ISR activation by CReP deletion may dampen ER stress response. Tunicamycin-mediated liver damage determined by ALT assay was comparable between WT and CReP LKO mice (Supporting Fig. S3E ). GCN2 phosphorylation was also unaffected in liver of CReP LKO mice (Fig. 1A) . These data indicate that CReP ablation increased eIF2α phosphorylation and turned on ISR signaling without inducing stress per se.
atF4-DepeNDeNt FgF21 eXpReSSIoN IN CRep lKo MICe pRoMoteS BeIge aDIpogeNeSIS aND IMpRoVeD gluCoSe HoMeoStaSIS
In mice, hepatic FGF21 is strongly induced by fasting. (28, 32, 33) Fed-state hepatic FGF21 mRNA and plasma FGF21 protein levels in CReP LKO mice were comparable to those of fasted WT mice ( Fig. 2A,B) . Fasting further increased FGF21 expression in CReP LKO mice ( Fig. 2A) . Hepatic FGF21 expression is controlled by several transcription factors, such as ATF4, cAMP-responsive element-binding protein H (CREBH), and peroxisome proliferator-activated receptor α (PPARα). (20, 28, (32) (33) (34) Whereas ATF4 mediates FGF21 expression during ER stress and amino acid insufficiency, (20, 24) CREBH and PPARα are critical for fasting-and ketogenic diet-mediated FGF21 expression. (28, 32, 34) Hepatic CREBH and PPARα mRNA and protein expression was largely unaffected by CReP deletion (Fig. 2B and Supporting Fig. S2 ). Representative CREBH-and PPARα-dependent genes were strongly induced by fasting similarly in both WT and CReP LKO livers (Supporting Fig. S4 ), indicating that CReP deletion had minimal effects on CREBH and PPARα expression and function, and that FGF21 induction in CReP LKO livers is independent of CREBH or PPARα. On the other hand, small interfering RNA (siR-NA)-mediated silencing of ATF4 drastically reduced hepatic FGF21 expression and plasma FGF21 levels in CReP LKO mice, along with other ATF4 target genes, such as Asns and Psat1 (Fig. 2C,D) , suggesting that ATF4 plays a critical role in FGF21 induction in CReP LKO liver. Interestingly, transfection of various combinations of transcription factors into HepG2 cells suggests that ATF4 is the most potent inducer of FGF21 expression, whereas CREBH and PPARα further augment ATF4-dependent FGF21 expression (Fig. 2E) .
Given the robust FGF21 production in CReP LKO mice, we next asked whether these mice exhibited metabolic phenotypes reflecting the beneficial effects of FGF21. CReP LKO mice contained strikingly brown-colored subcutaneous inguinal white adipose tissue (iWAT; Fig. 3A) , suggesting the browning of WAT. Indeed, hematoxylin and eosin (H&E) staining revealed abundant multilocular brown adipocyte-like cells in the iWAT of CReP LKO , but not in WT mice (Fig. 3A) . Brown adipocyte markers, such as Ucp1, deiodinase type 2, and ELOVL fatty acid elongase 3 (Elovl3) were also highly induced in the iWAT of CReP LKO mice ( Fig. 3B and Supporting Fig. S5A ), suggesting the occurrence of browning of WAT in these mice. Western blotting analysis showed marked induction of UCP1 protein in iWAT of CReP LKO mice (Fig. 3C ). UCP1 and Elovl3 mRNA levels were also increased in brown adipose tissue (BAT) of CReP LKO mice by 1.8-and 4-fold, respectively, compared to WT controls ( Fig. 3B and Supporting Fig. S5B ), which correlated well with denser eosinophilic staining of BAT sections of the former (Fig. 3A) . CReP deletion also increased UCP1 mRNA level in epididymal WAT (eWAT) of CReP LKO mice (Fig. 3B) . We next measured energy expenditure parameters in CReP LKO mice by indirect calorimetry. Compared to WT, CReP LKO mice exhibited markedly increased energy expenditure (EE), rates of O 2 consumption (VO 2 ), and CO 2 production (VCO 2 ; Fig. 3D ). Importantly, respiratory exchange ratio (RER) was significantly lower in CReP LKO mice, indicating a higher consumption of fat as energy source, consistent with the fat browning phenotype in these mice (Fig. 3D) . No difference was observed in food intake per animal and physical activity between WT and CReP LKO mice, whereas water intake per animal appeared higher in CReP LKO mice during the dark phase (Supporting Fig. S5C ). When normalized to body weight, CReP LKO mice exhibited higher intake of both food and water during the dark phase (Supporting Fig. S5D ). To test whether systemic insulin sensitivity was increased in CReP LKO mice, we performed the GTT and insulin tolerance test (ITT). Both GTT and ITT showed substantially improved insulin sensitivity and glucose homeostasis in CReP LKO mice (Fig. 3E,F) . Insulinmediated AKT phosphorylation in liver and WAT was also higher in CReP LKO mice compared to WT controls (Supporting Fig. S5E ). Taken together, these data indicate that CReP deletion in liver increases the production of FGF21, promotes the browning of WAT, and increases whole-body energy expenditure and insulin sensitivity.
CRep lKo MICe aRe ReSIStaNt to HFD-INDuCeD MetaBolIC aBNoRMalItIeS
We next evaluated the impact of CReP deletion on HFD-induced metabolic abnormalities, including obesity, IR, and HS. BW of CReP LKO mice before the start of HFD feeding was 17% lower compared to littermate controls (Fig. 4A) . After 10 weeks of HFD feeding, the difference in BW was more pronounced, with CReP LKO mice weighing 32% less compared to controls (Fig. 4A) . Importantly, the percentage of fat mass in CReP LKO mice was significantly reduced with a concomitant increase in lean mass percentage compared to WT controls, indicating the marked reduction in adiposity in CReP LKO mice (Fig. 4A ). HFD feeding increased blood glucose and serum insulin levels in WT mice (Fig. 4B) , reflecting the onset of IR. In contrast, CReP LKO mice maintained normal blood glucose and serum insulin levels during the course of HFD feeding (Fig. 4B) . Consistently, CReP LKO mice exhibited improved glucose homeostasis, as determined by GTT and ITT (Fig. 4C) .
CReP LKO mice maintained high serum FGF21 levels throughout HFD feeding, whereas HFD feeding only modestly increased serum FGF21 levels in WT mice (Fig. 4B) . This is likely attributed to the development of HS in these mice, which is known to induce FGF21 through PPARα and CREBH. (28) Indeed, HFD feeding induced HS in WT mice, as demonstrated by the presence of abundant lipid droplets in liver sections (Fig. 4D ) and biochemical quantification of hepatic TG content ( Figure 4E ). HFD-induced HS was markedly improved in CReP LKO mice (Fig. 4D,E) . We found that proteolytic activation of a key lipogenic transcription factor, sterol regulatory element-binding protein-1c (SREBP-1c; Fig. 4E ), and expression of its target lipogenic genes were down-regulated in CReP LKO livers (Fig. 4E) . We next examined whether increased whole-body energy expenditure might have contributed to the decreased adiposity and improved glucose and lipid homeostasis in CReP LKO mice. Indirect calorimetry revealed that VO 2 , VCO 2 , and energy expenditure were markedly increased in CReP LKO mice (Fig. 4F) .
Browning of WAT, as demonstrated by increased abundance of adipocytes containing multilocular lipid droplets (Fig. 4D) , and the induction of Ucp1, Elvol3, and other thermogenic genes in iWAT and BAT, was observed in HFD-fed CReP LKO mice (Supporting Fig. S6A,B) , consistent with the observation in chowfed mice. Plasma ketones tended to be elevated in CReP LKO mice, suggesting increased ketogenesis (Supporting Fig. S6C ). Plasma NEFA and TG levels were reduced in CReP LKO mice (Supporting Fig.  S6D,E) . These data suggest that ISR activation in CReP LKO mice increases the production of FGF21, which, in turn, increases whole-body energy expenditure, and confers protection of CReP LKO mice from diet-induced obesity and the associated metabolic disorders.
eFFeCtS oF aCute CRep DeletIoN IN tHe lIVeR
The profound improvement of metabolic parameters in CReP LKO mice suggests that ISR activation in the liver would be a potential therapeutic strategy to treat metabolic disorders. To investigate the effects of ISR activation in adult mice, we used recombinant adeno-associated virus (AAV) expressing Cre recombinase under the control of the liver-specific thyroxine-binding globulin promoter (AAV-cre). Injection of AAV-cre into Ppp1r15b loxP mice led to almost complete ablation of CReP mRNA expression (Supporting Fig. S7A ). As anticipated, Fg f21, Asns, and Psat1 were highly expressed in liver of the AAVcre-injected Ppp1r15b loxP mice (Supporting Fig. S7A) . Consistent with what we observed in CReP LKO mice, certain ER stress-inducible ATF4 target genes, such as Ddit3, and Ppp1r15a, were not induced by acute CReP deletion (Supporting Fig. S7B ). Nuclear XBP1s and phospho-PERK levels tended to be decreased in CReP-deleted livers (Supporting Fig. S7C ). Acute CReP deletion did not cause liver damage (Supporting Fig. S7D ). Ucp1 and Elov3 expression in iWAT and BAT were increased by AAVcre injection (Fig. 5A) , which correlated well with the appearance of adipocytes with small lipid droplets (Fig. 5B) . AAV-cre injection into Ppp1r15b loxP mice resulted in 6% reduction in BW and 20% reduction in blood glucose level within 3 days, which were maintained up to more than 4 weeks (Fig. 5C and data not  shown) . To further test the beneficial metabolic effects of CReP ablation in diet-induced obese mice, we injected AAV-cre into HFD-fed Ppp1r15b loxP mice. BW and blood glucose level gradually decreased over 2 weeks by 20% and 45%, respectively, in HFD-fed Ppp1r15b loxP mice injected with AAV-cre (Fig. 5C) . Remarkably, CReP ablation decreased fat mass, resulting in an increase of lean mass ratio in these mice (Fig. 5D) . ITT further revealed a dramatic improvement of insulin sensitivity by acute CReP deletion in DIO mice (Fig. 5E) . LS induced by HFD was also improved by AAV-cre injection ( Fig. 5F and Supporting Fig. S7E ).
Collectively, these data demonstrate that augmenting ISR in liver by CReP ablation has multiple beneficial metabolic effects on obesity and type 2 diabetes.
FgF21 IS CRItICal FoR MetaBolIC BeNeFIt IN CRep lKo MICe
To investigate the importance of FGF21 in the improved metabolic parameters of CReP LKO mice, we generated liver-specific CReP and FGF21 DKO mice by crossing CReP LKO with Fgf21 loxP mice. Loss of CReP and FGF21 mRNA expression in DKO liver was confirmed by quantitative real-time PCR (qPCR; Supporting Fig. S8A ). Induction of Ucp1 and Elovl3 mRNAs in CReP LKO mice were completely reversed by the concomitant loss of FGF21 in DKO mice (Fig. 6A,B) . As anticipated, browning of iWAT in CReP LKO mice was also reversed in DKO mice ( Figure 6C ). Increased EE, rates of VO 2 , and VCO 2 , and decreased RER in CReP LKO mice were normalized in DKO mice (Fig. 6E) . DKO mice had significantly higher BW than CReP LKO , suggesting that elevated FGF21 level is responsible for the delayed weight gain of CReP LKO mice (Fig. 6D) . The improved insulin sensitivity and glucose homeostasis of CReP LKO mice was also abolished by concomitant FGF21 ablation in DKO mice, as indicated by ITT and GTT ( Fig. 6F and Supporting Fig. S8B ). These data suggest that FGF21 is a critical ISR-regulated gene that confers metabolic benefits in CReP LKO mice.
Discussion
ISR has been appreciated as a cytoprotective mechanism against environmental stresses. Diminished protein synthesis by eIF2α phosphorylation is believed to conserve amino acids and energy, which could be used for the expression of ATF4-dependent cytoprotective genes. (2) Consistently, genetic ablation of eIF2α kinases or ATF4, or mutation at the phosphorylation site of eIF2α, causes various impairments in development, cell survival, and organ functions. (35) It is conceivable that augmenting ISR has beneficial effects on cell survival and function. Particularly in the liver, it has been shown that ISR activation results in a dramatic induction of FGF21, (23) (24) (25) implying a potential metabolic function of ISR. In this study, we explored the role of CReP in ISR activation in the liver, and the impact of ISR activation through CReP ablation on liver function. We found that CReP ablation caused constitutive eIF2α phosphorylation and activation of ATF4-dependent ISR target gene expression in the liver. ATF4-dependent FGF21 expression by CReP deletion conferred multiple metabolic benefits in HFD-induced obese mice, including weight loss, improved glycemic control, and protection from HS. This study shows that ISR activation in the liver is beneficial to systemic metabolic health. Strategies to target CReP or disrupt CReP-PP1 interaction could be promising methods to boost ISR. Phosphatase inhibitors could also be used to target ISR for the same purpose. For example, Salubrinal has been reported to inhibit phosphatase activation and therefore activate the ISR pathway. (36) It is necessary to investigate whether these methods could be applied to the treatment of metabolic diseases.
FGF21 is a hepatokine that has multiple metabolic activities, including improvement of obesity, hyperglycemia, dyslipidemia, and HS. (37) (38) (39) Accordingly, FGF21 signaling has received significant attention as a therapeutic target for antiobesity and antidiabetes drugs. (40, 41) Various approaches have been utilized to develop FGF21-based therapeutic molecules, including long-acting FGF21 analogs and agonist antibodies for FGF21 receptor complex. (40, 41) Targeting ISR represents a strategy to increase endogenous FGF21 expression. It is notable that plasma FGF21 level in CReP LKO mice is comparable to fasting-induced FGF21 level in WT mice, which might be beneficial in minimizing potential side effects of using supraphysiological doses of FGF21 mimetics.
Increased eIF2α phosphorylation by CReP deletion presumes that certain eIF2α kinases are basally active in normal mouse liver to provide phosphorylated eIF2α that would accumulate when its dephosphorylation is inhibited. Indeed, we were able to detect basal eIF2α phosphorylation in normal mouse liver, which was further enhanced in the absence of CReP. Similarly, silencing of CReP in cultured cells strongly increased eIF2α phosphorylation, suggesting the presence of basal eIF2α kinase activity in these cells. (5) (6) (7) We hypothesize that low-grade stress signals may be present in most cells under normal physiological conditions. The identity of basal stress and the kinase responsible for the basal eIF2α phosphorylation in various settings remain to be determined. ATF4 is considered a master transcriptional regulator of the ISR, regulating a variety of genes including those involved in amino acid biosynthesis and transport, redox regulation, and feedback regulation of ISR. (2, 42) ATF4 is also a potent FGF21 inducer. (20, 21) Knockdown of ATF4 expression by siRNA decreased FGF21 production in CReP-deficient liver, identifying ATF4 as a critical FGF21 inducer. CReP ablation in liver-specific FGF21 knockout mice failed to lower BW and increase insulin sensitivity, indicating that FGF21 is the critical factor downstream of the CReP/eIF2α/ ATF4 pathway responsible for the improved metabolic parameters in CReP LKO mice. In summary, we propose that CReP deletion activates a linear signaling pathway involving eIF2α phosphorylation, ATF4 translation, and FGF21 induction, which promotes increased energy expenditure, and subsequently improved obesity-related metabolic parameters (Fig. 7) . It is notable, however, that ISR affects many other genes at translational and transcriptional levels, which might also participate in metabolic regulation. For example, ATF5 is also highly induced in CReP knockout liver. Similar to ATF4, ATF5 mRNA has two short open reading frames in the 5′ UTR that allow preferential translation of ATF5 upon eIF2α phosphorylation. (43, 44) ATF5 is highly expressed in the liver and has emerged as an important regulator of mitochondrial respiration and cell proliferation. (43, (45) (46) (47) Given the increased ketone production in CReP LKO mice, ATF5 might stimulate fatty acid oxidation and oxidative phosphorylation in mitochondria, contributing to the increased energy expenditure and prevention of excessive TG accumulation in the liver. Future studies will define the role of ATF5 in CReP-deficient liver.
FIg. 7.
Loss of CReP in the liver causes ISR activation and improves metabolic health. CReP deletion causes constitutive eIF2α phosphorylation in the liver, which leads to activation of ATF4 transcriptional program including increased FGF21 production. FGF21 production in liver of CReP LKO mice promotes multiple beneficial effects on metabolism, including increased beige adipogenesis, energy expenditure, and insulin sensitivity, and decreased adiposity, plasma lipids, and LS.
